Cost comparison of the two agents was performed. Results: No statistically significant differences were seen between whole milk and iopamiro with respect to degree of bowel distention and gastrointestinal tract discrimination for all segments of bowel studied (p > 0.05). Mural visualization is better with whole milk compared with iopamiro (p < 0.05). Significantly more patients ranked milk as pleasant in taste compared with iopamiro (p < 0.05). Milk was better tolerated than iopamiro, with fewer gastrointestinal side effects, including abdominal discomfort (p = 0.065), cramping (p = 0.309), nausea (p = 0.001), vomiting (p = 0.003) and diarrhea (p = 0.347
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Milk --An Effective Low-Attenuation Computed Tomography Oral Contrast Medium
Multiple low-attenuation oral contrast agents have been studied. [5] [6] [7] [8] [9] [10] [11] Although air had been advocated as an alternative to high-attenuation oral contrast material for gastric and large-bowel imaging 12 , the production of artifacts and the requirement of wide window settings for viewing render it a suboptimal agent for soft-tissue contrast resolution. 13 Taking advantage of the inherent contrast between water attenuation and contrast material-enhanced bowel wall, Winter et al 6 used water as an oral contrast agent, resulting in excellent luminal and mucosal depiction of the upper gastrointestinal tract. However, the use of water requires the additional use of an upper gastrointestinal smooth muscle relaxant and does not provide adequate evaluation of the distal small bowel. Previous investigations of fatcontaining oral contrast agents such as one comprising 12.5% corn oil showed excellent gastrointestinal tract discrimination and mural visualization without a significant difference in patient tolerance as compared with barium suspension and iodine solutions. 7 However, such agents either are not commercially available or are fat-containing food supplements that are expensive. In addition, metoclopramide hydrochloride was required to promote gastrointestinal peristalsis inhibited by the high fat content. Moreover, such high fat content is often unacceptable to patients. Although polyethylene glycol (PEG) provides better small-bowel distention and reaches the colon more readily than a full-strength fiber mixture and water 14 , the high cost per examination and patients' dissatisfaction with this unpalatable mixture and its abdominal side effects such as diarrhea prevented the widespread adoption of PEG preparations.
Whole m i lk (4%) has been shown to be costeffective. The fat contained in whole milk effectively slows upper gastrointestinal tract motility, obviating the use of either smooth muscle relaxants or metoclopramide hydrochloride. Whole milk provides superior mural visualization and discrimination of the pancreas and duodenum compared with bariumbased contrast material and water. In addition, gastrointestinal tract distention and small-bowel discrimination were comparable to those in studies using a barium suspension and superior to imaging performed with water. 5 More recently, a newly developed low-attenuation 0.1% barium suspension (Volumen, E-Z-EM Inc.) has been shown to provide excellent gastrointestinal tract distention and superb visualization of mural features compared with barium suspension and a methylcellulose-water mixture. 12 We hypothesize that milk will be well tolerated, more cost-effective, better than iopamiro for mural visualization with similar degrees of gastrointestinal tract distention and discrimination as iopamiro.
Materials and Methods
This study was carried out in Radiology and Imaging Department of Bangabandhu Sheikh Mujib Medical University, Dhaka from January to December 2009. Two hundred and ten outpatients referred for both oral and IV contrast-enhanced abdominal CT were purposively assigned to receive either whole milk or iopamiro (iodinated positive contrast medium). No flavoring material was added to the whole milk.
Patients with history of lactose intolerance, allergy to iodinated contrast material and gastric surgery and serum creatinine greater than 1.5 mg/dL w e re excluded from the study. All patients enrolled in the study were informed of purpose of the study and consent was taken.
One hundred patients received 1000 mL of water mixed with iopamiro (40 mL) and 110 patients received 1000 mL of whole milk divided into four doses (250 mL 45 minutes before scanning, 250 mL 30 minutes, 250 mL 1 5 m i nutes and 250 mL immediately before scanning).
CT e x aminations of all study subjects were performed using a single slice spiral CT scanner (Hitachi) creating 10-mm sections. All examinations were performed using IV c o ntrast material (Iopamiro, 300). Neither IV g l ucagon nor metoclopramide hydrochloride was administered.
The studies were q u alitatively evaluated independently by radiologists for luminal distention of the duodenum, jejunum, and ileum, which was graded on a scale of 0-3, with 0 being no distention,without specific measurements. Non uniform duodenal distention was frequently noted, and thus the duodenum was radiographically divided into two portions for analysis, with duodenum 1 including the first two portions of the duodenum and duodenum 2 comprising the third and fourth portions of the duodenum. Mural visualization of stomach, duodenum, jejunum and ileum was graded on a scale of 0-3, with 0 being no visualization, 1 being minimal, 2 being good and 3 being excellent visualization. Discrimination of the bowel wall from pancreas, cyst and lymph nodes was also ranked on 0-3 scale, 0 being no, 1 being minimal, 2 being good visualization and 3 being excellent discrimination.
A questionnaire regarding oral contrast tolerability was provided to each patient after completion of CT. The patients were asked to rate the taste of the oral contrast material on a scale of 1-3, with 1 being intolerable, 2 being unpleasant but tolerable, and 3 being pleasant. In addition, the patients were also asked whether they had any difficulties while ingesting the entire volume of contrast material and whether they disliked drinking whole milk or oral contrast material. Side effects including abdominal discomfort or cramping, nausea, vomiting, flatulence, and diarrhea were recorded. A c o st comparison of the two agents was also performed.
Statistical analysis
Mean age differences between the milk and iopamiro groups were evaluated using the Student's unpaired t test. Sex distribution was calculated and the differences were evaluated with the chi-square test. Degree of bowel distention and discrimination in the two study groups using the aforementioned 4-point scale was assessed by each reviewer, and the percentage of cases receiving each score was calculated. Percentages of cases with mural visualization in each study group were calculated and the chi-square test was used to examine the differences between the two groups. A p value less than or equal to 0.05 was considered significant for all these statistical analyses.
Results
Among 110 patients receiving whole milk, 48% were women and 52% were men. Among 100 patients who received iodinated oral contrast, 45% were women and 55% were men. Patients who consumed milk were from 20--70 years (mean 50 ± 14.2) and those who ingested iodinated oral contrast were from 26--68 years (mean 52 ± 1 5 .8). Statistically no significant difference was seen between two groups with respect to sex or age. Table I shows statistically no significant difference between whole milk and iodinated oral contrast groups with respect to the degree of bowel distention in all segments of the bowel. Table III shows the difference in bowel segment discrimination for milk and iodinated contrast medium. But no statistically significant difference was observed. Table IV shows the tolerability results of patient for milk and iodinated contrast medium. Patients tolerated milk better. Table V shows gastrointestinal symptoms following ingestion of whole milk and iodinated oral contrast medium.
Cost Comparison
The cost for milk is significantly less than the cost for Iopamiro per study. Specifically, milk costs 60 BDT p e r study versus 900 BDT p e r study for iopamiro. 
Discussion
The increasing use of multidetector computed tomography (MDCT) and the rising popularity of volume imaging have renewed a need for efficacious low-attenuation oral contrast agents because traditional high-attenuation contrast agents interfere with image processing techniques. Low-attenuation agents have been shown to be valuable in the diagnosis of small-bowel disorders such as ischemia 15 , neoplasm 16 , and Crohn's disease. [17] [18] [19] Such agents have also been proven to be valuable in gastric and duodenal demarcation for the evaluation of pancreatic and biliary abnormalities. 20 Various low-attenuation oral contrast agents have been explored for use with abdominal CT. 21 Among these agents, whole milk has been shown to compare favorably with traditional positive oral contrast material in gastrointestinal tract distention and mural visualization. 5, 12 Our study focused on comparing the two agents with respect to effectiveness in bowel distention and mural visualization, patient acceptance, and cost.
We found statistically no significant differences between whole milk and iopamiro with respect to degree of bowel distention among all segments of visualization, but whole milk had better patient acceptance, fewer abdominal symptoms, and lower cost than iopamiro. With rising medical costs and an increasing volume of CT examinations performed for the evaluation of gastrointestinal abnormalities, an oral contrast agent that enables effective gastrointestinal tract evaluation while minimizing cost is ideal, and whole milk patient satisfaction and willingness to ingest milk may lead to higher patient compliance while undergoing CT e x aminations, which may lead to earlier detection and treatment of diseases.
Whole milk showed excellent antral distention compared with the small bowel. This phenomenon is probably because a portion of the oral contrast material was consumed immediately before scanning and it did not have sufficient time to exit the stomach. This situation is ideal for and is often used in pancreatic and biliary studies. 20 The slightly decreased distention in the distal duodenum is likely secondary to peristalsis propelling the contrast material that was administered 45-60 minutes before scanning into the distal small bowel, whereas the contrast material administered immediately before scanning had not yet reached the distal duodenum. Distention of the duodenum, especially the third portion, is further compromised by its anatomic situation between solid organs and vascular structures. Similar to the distention results, visualization of the antral, jejunal, and ileal walls was slightly better than visualization of the duodenal wall. The visualization results paralleling the distention data support the general observation that better bowel distention imparts better bowel wall visualization.
Intravenous (IV) glucagon was not used in either the milk or the iopamiro group, yet good gastrointestinal tract distention was achieved. Such a phenomenon is expected for milk because the fat contained in milk effectively slows peristalsis, resulting in superb distention. The elimination of pharmacologic effects of IV g l ucagon, such as inhibition of gastric emptying, is beneficial to patients in many respects.
In the study performed by Winter et al, the combination of water and glucagon was associated with nausea and emesis in 14% and 7% of patients, respectively. 6 Although it is uncertain whether these symptoms were due to the use of glucagon, the ionic IV contrast material, or a combination of the two, such adverse reactions increase patient discomfort and the risk of aspiration. In addition, the ability to forgo IV glucagon administration will reduce costs.
The results of our study show that whole milk is comparable for bowel distention to iopamiro and better in mural visualization. In the setting of better patient acceptance, fewer gastrointestinal symptoms after consumption, and lower cost, whole milk proves to be a cost-effective alternative to iopamiro as a low-attenuation oral contrast agent. The ability of this inexpensive medium to produce adequate bowel wall visualization provides considerable potential for further cost-effective applications of volume imaging with MDCT.
